AIDX
What one share of 20/20 Biolabs holds
Services – Testing Laboratories
20/20 Biolabs’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.29 |
|---|---|
| Profit | −$0.81 |
| Cash and investments | $0.37 |
| Debt | $0.06 |
| Book value | $0.13 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2024 | $0.36 | −$1.16 | — | −$0.54 | — | $0.31 |
| 2025 | $0.41 | −$0.76 | — | −$0.39 | — | −$0.00 |